Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

News SummaryMost relevantAll newsSector news 

Merck KGaA May Withdraw Research from Portugal over Debt-Report

07/09/2012 | 02:28am US/Eastern

German chemical company Merck KGaA (>> Merck KGaA) may withdraw future investments for research projects in Portugal worth tens of millions of euros unless the government hospitals stick to the agreed-upon debt repayments, German daily newspaper Financial Times Deutschland reports Monday.

Merck Portugal's manager Fritz Sacher told the paper the company's research projects are long-term and require mutual trust as a basis. "The Portuguese government's lacking payment habits undermine this trust," he is quoted as saying.

Portuguese government hospitals owe the pharmaceutical industry a total of more than 1.5 billion euros ($1.84 billion) and companies have to wait nearly 550 days on average until invoices are paid, FTD reports.

Some companies, including Roche Holding AG (ROG.VX), have already halted the sale of medications on credit to highly indebted countries like Portugal, Greece, Spain and Italy until outstanding debts are paid, the paper notes, but for many companies such drastic steps are difficult as they carry responsibility for people's wellbeing.

Withdrawing research projects is a way of putting pressure on the government, as Portugal is an attractive location for research investments, FTD says. "The conditions for certain research and human studies are as good as in the U.S., but it's significantly more cost-effective in Portugal," Sacher told the paper.

Newspaper website: http://www.ftd.de

Write to the Frankfurt Bureau at djnews.frankfurt@dowjones.com

Stocks mentioned in the article : Merck KGaA
React to this article
Latest news on MERCK KGAA
12:35a MERCK KGAA : May Sell Allergopharma for up to USD638 Million
11/26 MERCK KGAA : plans to sell its allergy business unit to cut debt: Bloomberg
11/26 MERCK KGAA : Gray Modules: New Dimension in Organic Photovoltaics for Buildings
11/25 MERCK KGAA : Study Findings from Merck KGaA Provide New Insights into Chromatogr..
11/25 MERCK KGAA : and Pfizer Receive Positive Opinion for Orphan Drug Designation for..
11/20 MERCK KGAA : compte sur l’Afrique pour sa croissance • Le Conseil d&r..
11/20 MERCK KGAA : Counts on Africa for Growth • Executive Board wraps up week of..
11/20 MERCK KGAA : Counts on Africa for Growth
11/19 MERCK KGAA : Reports from Merck KGaA Add New Data to Findings in Physiology and ..
11/19 MERCK KGAA : and the University of Cape Town to Develop a Drug Discovery Platfor..
News chart
Full-screen chart
Income Statement Evolution
More Financials